Well, MSB do have a checkered history with the FDA, but I guess there are three reasons for the current price hike.
1. They claim FDA has all but winked and nodded approval in pre-submission meetings based on data provided.
2. They have multiple drug submissions scheduled in the next 6-12 months so, even if one fails, there are others.
3. There has been a lot of insider buying (tens of millions of shares) in the last couple of months.
I have a much smaller stake in MSB than in BOT so I haven't paid as much attention to the latest details.
Ann: Botanix $70 Million Institutional Capital Raising, page-144
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
-0.010(2.41%) |
Mkt cap ! $734.6M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 42.5¢ | 39.5¢ | $3.680M | 8.989M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 297011 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 12027 | 3 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |